Neose Technologies Inc (NTEC1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
CEO:
Zeev Weiss
Employees:
83
12 HARTOM STREET, HAR HOTZVIM, JERUSALEM, ISRAEL 777512
97225864657

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Intec Pharma Ltd. is a development stage company, which engages in the development of technology which enables the gastric retention of certain drugs. Its technology reduces side-effects and effective doses of drugs. The company was founded by Zvi Joseph in 2000 and is headquartered in Jerusalem, Israel.

Data derived from most recent annual or quarterly report
Market Cap 329.568 Million Shares Outstanding54.474 Million Avg 30-day Volume 303.169 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.96
Price to Revenue0.0 Debt to Equity0.0 EBITDA-12.981 Million
Price to Book Value0.0 Operating Margin0.0 Enterprise Value0
Current Ratio2.337 EPS Growth0.885 Quick Ratio1.948
1 Yr BETA 0.0 52-week High/Low 0.0 / Profit Margin0.0
Operating Cash Flow Growth60.3602 Altman Z-Score0.0 Free Cash Flow to Firm -6.869 Million
View SEC Filings from NTEC1 instead.

View recent insider trading info

Funds Holding NTEC1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NTEC1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HAYES WILLIAM B

  • Director
0 2021-07-23 1

MECKLER JEFFREY A CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
2,460 2021-07-23 1

MADDALUNA ANTHONY J

  • Director
670 2021-07-23 1

POMERANTZ ROGER

  • Director
0 2021-07-23 1

LINSCOTT WALT ADDISON CHIEF BUSINESS OFFICER

  • Officer
0 2021-07-23 1

KARAH HILA

  • Director
0 2021-07-23 1

SASSI NIR CHIEF FINANCIAL OFFICER

  • Officer
0 2021-07-23 1

HAMILTON WILLIAM F PHD

  • Director
70,821 2009-01-27 0

MACMASTER JR DOUGLAS J

  • Director
58,047 2009-01-27 0

GAGE L PATRICK

  • Director
75,397 2009-01-27 0

DOVEY BRIAN H

  • Director
2,869 2009-01-27 0

PARKER H STEWART

  • Director
2,869 2009-01-27 0

BARCLAYS PLC

  • 10% Owner
16,900,002 2008-12-31 0

TANG KEVIN C

TANG CAPITAL MANAGEMENT LLC

TANG CAPITAL PARTNERS LP

  • 10% Owner
10,412,306 2008-09-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments